Farmakoterapia w Psychiatrii i Neurologii

Full text

2/2021 vol. 37
Case report

Beneficial effect of lithium in female patient with bipolar affective illness and psoriasis

Przemysław Filipiak 1
,
Anna Jaskóła 1
,
Karolina Gattner 1
  1. HCP Medical Centre, Poznań
Farmakoterapia w Psychiatrii i Neurologii 2021, 37 (2), 165–171
DOI: https://doi.org/10.33450/fpn.2021.05.002
Data publikacji online: 2021/12/07
Article file
05R_IPiN_FARM_2021-2C-2.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Alda M, Cavazzoni P, Grof P. Treatment response to prophylactic lithium and family history of psychiatric disorders. Biol Psychiatry 1999; Apr 15; 45(8): 1078. DOI: 10.1016/s0006-3223(98)00314-x. PMID: 10386197.
  2. Blier P, Slater S, Measham T, Koch M, Wiviott G. Lithium and clozapine-induced neutropenia/agranulocytosis. Int Clin Psychopharmacol 1998; 13: 137-140.
  3. Brauchli YB, Jick SS, Curtin F, Meier CR. Lithium, antipsychotics, and risk of psoriasis. J Clin Psychopharmacol 2009; 29: 134-140.
  4. Carter TN. The relationship of lithium carbonate to psoriasis. Psychosomatics 1972; 13: 325-327.
  5. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54: 597-606.
  6. D’Onofrio S, Mahaffey S, Garcia-Rill E. Role of calcium channels in bipolar disorder. Curr Psychopharmacol 2017; 6: 122-135.
  7. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007; 25: 606-615.
  8. Grof P. Excellent lithium responders: People whose lives have been changed by lithium prophylaxis. In: Birch NJ, Gallicchio VS, Becker RW (Ed.). Lithium: 50 years of psychopharmacology, new perspectives in biomedical ;Cheshire: Weidner Publishing Group, 1999:36‐51.
  9. Jabłońska S, Majewski S. Choroby skóry i choroby przenoszone drogą płciową; Wydawnictwo Lekarskie PZWL, wyd. 1 , Warszawa 2002.
  10. Jaeschke R. Kompendium psychofarmakoterapii. Część 5: Lit. Charakterystyka ogólna, farmakokinetyka, mechanizmy działania, praktyka kliniczna; Medycyna Praktyczna; Psychiatria; 2018; 2: 27-42.
  11. Jafferany M. lithium and psoriasis: what primary care and family physicians should know. Prim Care Companion J Clin Psychiatry 2008; 10: 436-439.
  12. Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet Dermatol 2010; 3(1): 32-38.
  13. Nenman A, Adamski Z. Aspekty kliniczne i epidemiologiczne zaburzeń ogólnoustrojowych u chorych na łuszczycę. Forum Medycyny Rodzinnej 2009; 3: 447-453.
  14. Ockenfels HM, Nussbaum G, Schultewolter T, Mertins K, Wagner SN, Goos M. Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. Dermatology 1995; 191: 217-225.
  15. O’Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 2006; 5: 426-32.
  16. Remlinger-Molenda A, Wójciak P, Michalak M, Rybakowski J. Ocena aktywności wybranych cytokin w epizodzie maniakalnym i depresyjnym choroby afektywnej dwubiegunowej. Psychiatr Pol 2012; 46: 599-611.
  17. Rybakowski J. Neuroimmunologia zaburzeń psychicznych. W: Bilikiewicz A, Pużyński S, Rybakowski J, Wciórka J (red.). Psychiatria, t. 1. Urban & Partner, Wrocław 2002: 208.
  18. Rybakowski J. Lit – niezwykły lek w psychiatrii; Termedia 2019, Poznań.
  19. Rybakowski JK, Chłopocka-Woźniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970s and 1980s. Bipolar Disord 2001; 3(2): 63-67.
  20. Sarantidis D, Waters B. A review and controlled study of cutaneous conditions associated with lithium carbonate. Br J Psychiatry 1983 143: 42-50.
  21. Skoven I, Thormann J. Lithium compound treatment and psoriasis. Arch Dermatol 1979; 115: 1185-1187.
  22. Świerkosz A, Siwek M, Dudek D. Wpływ terapii litem na występowanie zmian opryszczkowych – opis przypadku. Farmakoterapia w Psychiatrii i Neurologii 2016; 32; 255-261.
  23. Tsankov N, Angelova I, Kazandjieva J. Drug-induced psoriasis. Am J Clin Dermatol 2000; 1: 159-165.
SUBMIT YOUR PAPER
Share
without publication fees
without publication fees
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications